No abstract available
Plain language summary
This Viewpoint discusses laws mandating insurance coverage of biomarker testing to broaden access to care for patients with cancer.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Biomarkers* / analysis
-
Humans
-
Insurance Coverage* / economics
-
Insurance Coverage* / legislation & jurisprudence
-
Insurance, Health* / economics
-
Insurance, Health* / legislation & jurisprudence
-
Neoplasms* / diagnosis
-
Neoplasms* / economics
-
State Government*
-
United States